Hologic (HOLX) Tops Q4 EPS by 61c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2021
November 1, 2021 4:01 PM EDTRevenue of $1.317 Billion Exceeds Expectations
Company Posts GAAP Diluted EPS of $1.28, Non-GAAP Diluted EPS of $1.61
Financial Guidance for Fiscal 2022 Anticipates Solid Growth in Core Womens Health Businesses and Continued Contributions to COVID-19 Fight
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Companys financial results for the fiscal fourth quarter ended September 25, 2021.
Our excellent top- and bottom-line results in the fourth quarter of fiscal 2021 exceeded expectations and capped off a remarkable year, said Steve MacMillan, the Companys chairman,... More
